Jiangsu: Special graphite new materialproduction project landed in Suyin Industrial Park
On November 7, "special graphite newmaterial production project" invested by Jiangsu Hongji High-TechMaterials Co., Ltd. was officially signed in Suyin Industrial Park. SuyinIndustrial Park Management Committee, Jiangsu Hongji Company and Suyin DevelopmentCompany signed the investment cooperation agreement together, and the signingwas witnessed on the line by China-Singapore Suzhou Industrial Park DevelopmentGroup Co.
The first phase of Jiangsu Hongji specialgraphite new material production project has a total investment of 1.5 billionRMB and will be built in two phases, which can realize 50,000 tons of isostaticnew material production capacity after reaching production. The first phase ofthe project is expected to start construction in the first half of 2023 and putinto production in 2024. The annual output value is expected to be 6 billionyuan and the annual comprehensive tax contribution is 600 million yuan afterthe first phase reaches production. After the completion of the project, itwill provide upstream raw material support for the photovoltaic industry inYinchuan City and achieve the goal of strengthening and extending the chain.
Ltd. is a manufacturer of isostaticgraphite materials in China. Its main products are isostatic graphite productsfor photovoltaic industry, which are mainly used in photovoltaic industry andhave been expanded to high-end mold field. In the field of photovoltaic, thecompany's products are used to make hot field components for long crystalfurnaces, and the end products are used in Yinchuan Longi, Zhonghuan and otherfamous silicon wafer enterprises such as Jinko and Shangji outside the region,which will effectively solve the problem of shortage of consumables related tohot field for crystalline silicon manufacturing. In the future, the companywill also focus on the industrial layout of nuclear graphite, ultra-fineparticles of isostatic graphite, to the high-end market monopolized by foreigncompanies, to achieve domestic substitution.
Since this year, Suyin Industrial Park hasbeen closely focusing on the strategic layout of developing "threenew" industries and building "two capitals and five bases" inYinchuan City, taking chain and scale as the direction, and carrying outprecise investment in the fields of new energy and new materials in YangtzeRiver Delta and the Middle East. Industry chain investment, has signed a numberof industry chain key link projects such as Jiangsu Zhifu environmentalprotection photovoltaic components, and strive to build momentum for theconstruction of 100 billion level park empowerment, for the "early zonedemonstration city" and "innovation development leading city"construction to contribute to the power of Suyin.
Looking for chemical products? Let suppliers reach out to you!
2026-07-01
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
CPHI China 2026 Concludes Successfully, ECHEMI Serves Global Pharmaceutical Clients
-
From API China to the Global Pharmaceutical Chain: ECHEMI Is Reshaping the "New Speed" of Pharmaceutical Trade
-
On the Second Day of the 93rd API China: ECHEMI Advances Global Dialogue in the Pharmaceutical Industry Through Innovative Practices
-
Review of the 93rd API China: In Chongqing, Witnessing the Global Pulse of the Pharmaceutical Industry
-
Understand the New Rules to Enter the Market | ECHEMI × API China 2026 Overseas Pharmaceutical Market & Product Trends Conference Successfully Concluded
-
ECHEMI WPO and Pharmaceutical Division Showcase Dual Strengths at the 94th API China, Tackling Pharmaceutical Export Challenges with Precision
-
72 Hours at API China: Where China’s API Export Industry Is Heading Next
-
When Global Buyers No Longer Visit Trade Shows but “Select Suppliers with a Click”
-
When Global Buyers Sit at the Same Table, Chinese Suppliers Respond: A Real 1-on-1 Online Business Matching Event
-
ECHEMI and CPHI China Jointly Host Pharmaceutical Business Match-making Event